date:Dec 09, 2013
Royal DSM, the global Life Sciences and Materials Sciences company, has repurchased 164,545 of its own shares in the period from 29 November 2013 up to and including 5 December 2013 at an average price of 57.17. This is in accordance with the repurchase, covering existing option plans, announced on 6 November 2013. The consideration of this repurchase was 9.4 million.
The total number of shares repurchased under this program to date is 926,598 shares for a total consideration of 54.1 million.